Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

Register to chat with this document.

RNS - The European Commission approves Bio-Thera’s BAT2206 (USYMRO®, a biosimilar ustekinumab), to be commercialized by Richter in Europe

Company: Chemical Works of Gedeon Richter Plc Date: 2025-08-27 Language: Hungarian Register to download

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method: